AI assistant
IO Biotech, Inc. — Director's Dealing 2021
Nov 5, 2021
34883_dirs_2021-11-04_f912e0fa-570d-497e-b4b6-4d2d4b7074e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2021-11-04
Reporting Person: Glaub Kathleen Sereda (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants (Right to Buy) | $16.86 | Common Stock (4901) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (12935) | Direct | ||
| Warrants (Right to Buy) | $19.62 | Common Stock (1176) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (12648) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (48843) | Direct |
Footnotes
F1: These Warrants vested in 25% annual increments on December 31 of each year following the November 7, 2017 grant date.
F2: Warrants expire in annual increments on the fifth anniversary of the vesting date.
F3: These Warrants vest in 1/48 monthly increments after the May 27, 2021 vesting commencement date, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.
F4: These Warrants vest in 1/48 monthly increments after October 15, 2021 vesting commencement date, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.